Published April 18, 2017
| Version v1
Patent
Open
Antibody-light fusion products for cancer therapeutics
Contributors
Patent applicant:
Description
Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.
Files
US9623116.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:40d891fb855e06300f7347499938155b
|
1.1 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201514717808 A
- Patent number
- US 9623116 B2
- Other
- oai:uchicago.tind.io:8090
Dates
- Patent filed
-
2015-05-20